Alexandre Bleibtreu

Alexandre Bleibtreu is a Professor at Université Paris-Est Créteil - Paris 12, affiliated with the Department of Microbiology under the Faculty of Medicine. He holds a Doctorate in Microbiology from Université Paris Diderot (2014) and a Medical Doctorate from Université Pierre et Marie Curie (2014). His research focuses on bacterial pathogenesis, antibiotic resistance, and clinical microbiology, particularly in contexts such as pregnancy and immunosuppressed patients. He has supervised multiple theses, including directing Dahlia Aggoun’s 2023 study on prophylaxis in cardiac transplant patients. His work bridges basic microbiology with clinical applications, addressing urgent public health challenges.

Education:

• PhD in Microbiology, Université Paris Diderot - Paris 7 (2014)
• Medical Doctorate, Université Pierre et Marie Curie - Paris 6 (2014)

Research Interests: E. coli virulence mechanisms, bacterial stress response, antibiotic resistance in clinical settings, and translational medicine. His studies investigate how bacterial traits influence infection outcomes in vulnerable populations like pregnant women and transplant recipients. Recent Work: The 2023 study on cotrimoxazole prophylaxis highlights his commitment to improving infection prevention strategies in immunocompromised patients. Earlier work on pregnancy-associated E. coli sepsis underscores his clinical focus on maternal health.